Chendong Pan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Chendong Pan has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- David H. Thompson
Department of Chemistry, Multidisciplinary Cancer Research Facility, Purdue University, 1203 W. State Street, West Lafayette, Indiana 47907, United States
1 shared publication - Dena Almeida
Microscopy and Image Analysis Core, Weill Cornell Medical College, Cornell University 5 , New York City, NY
1 shared publication Enrique Rodriguez-Boulan
Department of Ophthalmology, Weill Cornell Medicine, Margaret Dyson Vision Research Institute, New York, NY 10065
1 shared publicationGuillermo L. Lehmann
Department of Ophthalmology, Weill Cornell Medicine, Margaret Dyson Vision Research Institute, New York, NY 10065
1 shared publicationIgnacio Benedicto
Department of Ophthalmology, Weill Cornell Medicine, Margaret Dyson Vision Research Institute, New York, NY 10065
1 shared publication- Kalpita Banerjee
Weil Cornell Medical College, Ophthalmology Department, Dyson Research Institute, 1300 York Avenue, New York, New York 10065, United States
1 shared publication
Latest Publications
- 15 November 2021
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 118 (47)
Lipofuscin causes atypical necroptosis through lysosomal membrane permeabilization
Significance: Retinal lipofuscin causes retinal pigment epithelium cell death in Stargardt and potentially dry–Age-Related Macular Degeneration (AMD). The current dogma is that lipofuscin’s cytotoxicity results from the light-triggered decomposition of its lipid-bisretinoids leading to apoptosis. However, antiapoptotic antioxidants or light-blocking lenses are not effective to stop degeneration in Stargardt and most AMD patients. Here, we show that lipofuscin forms aggregates in lysosomes, which trigger lysosomal membrane permeabilization and subsequent atypical necroptosis. We provide evidence that necrosulfonamide, necrostatin-7, and arimoclomol can effectively control this lethal cascade.
- 15 November 2021
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 118 (47)
Lipofuscin causes atypical necroptosis through lysosomal membrane permeabilization
Significance: Retinal lipofuscin causes retinal pigment epithelium cell death in Stargardt and potentially dry–Age-Related Macular Degeneration (AMD). The current dogma is that lipofuscin’s cytotoxicity results from the light-triggered decomposition of its lipid-bisretinoids leading to apoptosis. However, antiapoptotic antioxidants or light-blocking lenses are not effective to stop degeneration in Stargardt and most AMD patients. Here, we show that lipofuscin forms aggregates in lysosomes, which trigger lysosomal membrane permeabilization and subsequent atypical necroptosis. We provide evidence that necrosulfonamide, necrostatin-7, and arimoclomol can effectively control this lethal cascade.